Lucid Diagnostics | SC 13G/A:超过5%持股股东披露文件(修正)-Ayrton Capital LLC(9.9%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.9%)等
Lucid Diagnostics | 4:持股变动声明-董事 Matheis Dennis
Lucid Diagnostics | 3:首次持股声明-董事 Matheis Dennis
Lucid Diagnostics | 4:持股变动声明-高管 O'Neil Shaun
Lucid Diagnostics | 4:持股变动声明-高管 Gordon Michael Adam
Lucid Diagnostics | 4:持股变动声明-高管 MCGRATH DENNIS M
Lucid Diagnostics | 4:持股变动声明-高管 Aklog Lishan
Lucid Diagnostics | 4:持股变动声明-董事 Lapidus Stanley
Lucid Diagnostics | 4:持股变动声明-董事 Sparks Ronald M
Lucid Diagnostics | 4:持股变动声明-董事 White Debra
Lucid Diagnostics | 4:持股变动声明-董事 Cox James L
Lucid Diagnostics | 4:持股变动声明-董事 SOKOLOV JACQUE J
Lucid Diagnostics | 4:持股变动声明-股东 PAVmed Inc.
Lucid Diagnostics | SC 13D/A:超过5%持股股东披露文件(修正)-PAVmed Inc.(65.2%)
Lucid Diagnostics | SC 13G:超过5%持股股东披露文件-Ayrton Capital LLC(9.9%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.9%)等
Lucid Diagnostics | SC 13D/A:超过5%持股股东披露文件(修正)-PAVmed Inc.(72.2%)
Lucid Diagnostics | 4:持股变动声明-股东 PAVmed Inc.
Lucid Diagnostics | D:发行公告
Lucid Diagnostics | 4:持股变动声明-董事 Lapidus Stanley
Lucid Diagnostics | 4/A:持股变动声明(修正)-董事 Lapidus Stanley
暂无数据
暂无数据